IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation

Your review change was submittedDuplicate this Experiment Add a new Signature

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/17

Curator: Kwekuamoo

Revision editor(s): LGeistlinger, Kwekuamoo, WikiWorks, Atrayees

Subjects

Location of subjects: Italy

Host species Species from which microbiome was sampled. Contact us to have more species added.: Homo sapiens

Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology: Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology: Irritable bowel syndrome [X]Psychogenic IBS,Adaptive colitis,Colitides, Mucous,Colitis, Mucous,Colon spasm,Colon, Irritable,Functional bowel disease,IBD,IBS,IBS - Irritable bowel syndrome,IC - Irritable colon,Irritable bowel,Irritable bowel - IBS,irritable bowel syndrome,Irritable Bowel Syndromes,Irritable Colon,irritable colon,Irritable colon (disorder),Irritable colon - Irritable bowel syndrome,Irritable colon syndrome,Membranous colitis,Mucous Colitides,Mucous colitis,mucus colitis,Nervous colitis,Psychogenic IBS,psychogenic IBS,Spastic colitis,Spastic colon,spastic colon,Syndrome, Irritable Bowel,Syndromes, Irritable Bowel,Irritable bowel syndrome

Group 0 name Corresponds to the control (unexposed) group for case-control studies: Healthy Control

Group 1 name Corresponds to the case (exposed) group for case-control studies: IBS

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group: Fulfilled the Rome III criteria for the diagnosis of IBS.

Group 0 sample size Number of subjects in the control (unexposed) group: 24

Group 1 sample size Number of subjects in the case (exposed) group: 19

Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any): 2 months

Lab analysis

Sequencing type: 16S

16S variable region One or more hypervariable region(s) of the bacterial 16S gene: V2-V3

Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance: HTF-Microbi.Array

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).: relative abundances

Statistical test: Kruskall-Wallis

Significance threshold p-value or FDR threshold used for differential abundance testing (if any): 0.05

MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?: Yes

Matched on Factors on which subjects have been matched on in a case-control study: sex, age

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness: unchanged

Richness Number of species: unchanged

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: increased abundance in IBS

NCBI	Quality Control	Links
Shouchella clausii
Bacillus cereus
Bifidobacteriaceae
Bifidobacterium adolescentis
Bifidobacterium breve
Bifidobacterium longum
Campylobacter
Clostridioides difficile
Enterobacteriaceae
Enterococcus faecium
Lactobacillaceae
Lentilactobacillus buchneri
Ligilactobacillus salivarius
Peptostreptococcaceae
Agathobacter rectalis

Revision editor(s): Kwekuamoo

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo, Atrayees

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: decreased abundance in IBS

NCBI	Quality Control	Links
Bacteroides
Veillonella
Prevotella

Revision editor(s): Kwekuamoo, Atrayees

Experiment 2

Your review change was submittedDuplicate this Experiment Add a new Signature

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): LGeistlinger, Kwekuamoo, WikiWorks, Atrayees

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies: IBS-C

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group: Fulfilled the Rome III criteria for the diagnosis of IBS. Constipation IBS (IBS-C)

Group 1 sample size Number of subjects in the case (exposed) group: 4

Lab analysis

Statistical Analysis

Matched on Factors on which subjects have been matched on in a case-control study: age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness: unchanged

Richness Number of species: unchanged

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: increased abundance in IBS-C

NCBI	Quality Control	Links
Shouchella clausii
Bifidobacteriaceae

Revision editor(s): Kwekuamoo

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo, Atrayees

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: decreased abundance in IBS-C

NCBI	Quality Control	Links
Bacteroides
Prevotella

Revision editor(s): Kwekuamoo, Atrayees

Experiment 3

Your review change was submittedDuplicate this Experiment Add a new Signature

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): LGeistlinger, Kwekuamoo, WikiWorks, Atrayees

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies: IBS-D

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group: Fulfilled the Rome III criteria for the diagnosis of IBS. Diarrhea IBS (IBS-D).

Group 1 sample size Number of subjects in the case (exposed) group: 10

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness: unchanged

Richness Number of species: unchanged

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: increased abundance in IBS-D

NCBI	Quality Control	Links
Shouchella clausii
Bacillus cereus
Bifidobacteriaceae
Bifidobacterium adolescentis
Bifidobacterium breve
Bifidobacterium longum
Clostridioides difficile
Enterobacteriaceae
Enterococcus faecium
Lactobacillaceae
Ligilactobacillus salivarius
Peptostreptococcaceae
Agathobacter rectalis

Revision editor(s): Kwekuamoo

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): Kwekuamoo, Atrayees

Source: Table 1.

Description: Bacterial groups significantly altered in IBS subjects (IBS; Constipation IBS, C-IBS; Diarrhea IBS, D-IBS; Mixed IBS, M-IBS), with respect to healthy subjects (HS)

Abundance in Group 1: decreased abundance in IBS-D

NCBI	Quality Control	Links
Bacteroides
Prevotella

Revision editor(s): Kwekuamoo, Atrayees

Experiment 4

Your review change was submittedDuplicate this Experiment Add a new Signature

Reviewed Marked as Reviewed by Atrayees on 2023-6-30

Curated date: 2021/07/18

Curator: Kwekuamoo

Revision editor(s): LGeistlinger, Kwekuamoo, WikiWorks, Atrayees

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies: IBS-M

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group: Fulfilled the Rome III criteria for the diagnosis of IBS. Mixed IBS (IBS-M).

Group 1 sample size Number of subjects in the case (exposed) group: 5

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness: unchanged

Richness Number of species: unchanged

Signature 1